At Nostos Genomics, we partner with genetic testing labs to turn data into genomic insights and give more people with genetic diseases a fast and clear diagnosis. Over 300 million people live with a rare genetic disease, and for most, the journey from the first symptoms to a diagnosis takes more than 5 years. Even after that, diagnoses are often incorrect, and many people end up not being diagnosed at all.

New technology now allows millions to benefit from genetic testing for diagnosis, while targeted therapies for previously untreatable disorders are being developed. However, the last step in genetic testing 1 interpreting mutations remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Due to limited understanding of mutation consequences, 70% of people undergoing genetic tests remain undiagnosed.

Our CE-certified platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering this platform to labs, we enable them to diagnose more people in a fraction of the time.

Our vision is to help people with genetic diseases start a new journey by improving the accuracy, speed, and accessibility of genetic testing, providing patients with the right information at the right time, empowering informed health decisions.

We aim to make a difference in genetic medicine by addressing the bottleneck in interpreting variant data from genetic sequencing. Our journey started with the belief that better interpretation technology will expand access and improve outcomes in healthcare.

We operate as a proud, diverse, international group of creative problem solvers who value transparency, kindness, personal responsibility, and positive impact on society.